Bioscience Health Innovations, Revenue Growth Rates (BHIC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
BioScience Health Innovations, Inc.  (OTC: BHIC)
 

BHIC's Revenue Growth by Quarter and Year

Bioscience Health Innovations,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BHIC Revenue (in millions $) FY 2027 FY 2026 FY 2025 FY 2024
4th Quarter December -
3rd Quarter September -
2nd Quarter June 1.04
1st Quarter March 0.75
FY 1.79





BHIC Revenue second quarter 2027 Y/Y Growth Comment
Bioscience Health Innovations, Inc. reported fall in Revenue in the second quarter 2027 by -41.12% to $ 1.04 millions, from the same quarter in 2026.
The drop in the second quarter 2027 Bioscience Health Innovations, Inc.'s Revenue compares unfavorably to the Company's average Revenue doubling of 296.53%.

According to the results reported in the second quarter 2027, Bioscience Health Innovations, Inc. achieved the best Revenue growth in Cloud Computing & Data Analytics industry. While Bioscience Health Innovations, Inc.' s Revenue drop of -41.12% ranks overall at the positon no. 0 in the second quarter 2027.


BHIC Revenue ( Y/Y Growth %) 2027
 2026 2025 2024
4th Quarter December - 157.38 % 103.33 % -
3rd Quarter September - 98.25 % 200 % 850 %
2nd Quarter June -41.12 % 363.16 % 442.86 % -
1st Quarter March -39.02 % 339.29 % 833.33 % -
FY   - 209.24 % 211.86 % -

Financial Statements
Bioscience Health Innovations,'s second quarter 2027 Revenue $ 1.04 millions BHIC's Income Statement
Bioscience Health Innovations,'s second quarter 2026 Revenue $ 1.76 millions Quarterly BHIC's Income Statement


BHIC Revenue (Quarter on Quarter Growth %)

 2027
 2026 2025 2024
4th Quarter December - 38.94 % 7.02 % 57.89 %
3rd Quarter September - -35.8 % 50 % 171.43 %
2nd Quarter June 38.18 % 43.09 % 35.71 % 133.33 %
1st Quarter March -52.23 % 101.64 % -6.67 % -
FY (Year on Year)   - 209.24 % 211.86 % -


Back to BHIC Growth rate Comparisons >> Back to BHIC Growth rate Comparisons >>


Revenue second quarter 2027 Y/Y Growth Company Ranking
Within: No.
Cloud Computing & Data Analytics Industry #
Technology Sector #
Overall #0

Revenue Y/Y Growth Statistics
High Average Low
875.63 % 296.53 % -41.03 %
(Jun 30 2025)   (Jun 30 2026)
Revenue second quarter 2027 Y/Y Growth Company Ranking
Within: No.
Cloud Computing & Data Analytics Industry #
Technology Sector #
Overall #0
Revenue Y/Y Growth Statistics
High Average Low
875.63 % 296.53 % -41.03 %
(Jun 30 2025)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2024, 2025, 2026, 2027

Bioscience Health Innovations,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
176.55 % 33.47 % -100 %
(Sep 30 2023)  


BHIC's II. Quarter Q/Q Revenue Comment
BioScience Health Innovations, Inc. achieved in the II. Quarter 2027 above company average sequential Revenue jump of 38.18%, to $ 1.04 millions, from $0.75 millions in the first quarter.

Within Cloud Computing & Data Analytics industry BioScience Health Innovations, Inc. achieved highest sequential Revenue growth. While Bioscience Health Innovations,'s Revenue growth quarter on quarter, overall rank is 0.


Revenue Q/Q Growth Company Ranking
Within: No.
Cloud Computing & Data Analytics Industry #
Technology Sector #
Overall #0
Revenue Q/Q Growth Company Ranking
Within: No.
Cloud Computing & Data Analytics Industry #
Technology Sector #
Overall #0
Revenue Q/Q Growth Statistics
High Average Low
176.55 % 33.47 % -100 %
(Sep 30 2023)  


BHIC's II. Quarter Q/Q Revenue Comment
BioScience Health Innovations, Inc. achieved in the II. Quarter 2027 above company average sequential Revenue jump of 38.18%, to $ 1.04 millions, from $0.75 millions in the first quarter.

Within Cloud Computing & Data Analytics industry BioScience Health Innovations, Inc. achieved highest sequential Revenue growth. While Bioscience Health Innovations,'s Revenue growth quarter on quarter, overall rank is 0.


Bioscience Health Innovations,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 4.49 $ 5.21 $ 5.69 $ 4.73 $ 4.17
Y / Y Revenue Growth (TTM) 7.76 % 86.53 % 208.33 % 207.22 % 260.04 %
Year on Year Revenue Growth Overall Ranking # 194 # 104 # 75 # 67 # 61
Seqeuential Revenue Change (TTM) -13.83 % -8.37 % 20.37 % 13.4 % 49.14 %
Seq. Revenue Growth (TTM) Overall Ranking # 194 # 104 # 75 # 67 # 61


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Bioscience Health Innovations,'s cumulative twelve months Revenue were $ 4 millions, company would post below average annual Revenue growth of 49.14% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Bioscience Health Innovations,'s Revenue growth from the 2.7944999999999998% growth in Mar 31 2026. Despite that, Bioscience Health Innovations, showed the highest Revenue growth, among it's peers in Cloud Computing & Data Analytics industry.

BioScience Health Innovations, Inc. achieved highest trailing twelve month year on year Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 104 to 194.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Cloud Computing & Data Analytics Industry #
Technology Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
260.04 %
 172.88 %
7.76 %
(Jun 30 2025)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Bioscience Health Innovations,'s cumulative twelve months Revenue were $ 4 millions, company would post below average annual Revenue growth of 7.76% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Bioscience Health Innovations,'s Revenue growth from the 2.7944999999999998% growth in Mar 31 2026. Despite that, Bioscience Health Innovations, showed the highest Revenue growth, among it's peers in Cloud Computing & Data Analytics industry.

BioScience Health Innovations, Inc. achieved highest trailing twelve month year on year Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 104 to 194.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Cloud Computing & Data Analytics Industry #
Technology Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
260.04 %
172.88 %
7.76 %
(Jun 30 2025)  






Other Revenue Growth
Cloud Computing & Data Analytics Industry Revenue Growth Trends and Statistics
Technology Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BHIC's Revenue Growth Ratio versus Cloud Computing & Data Analytics Industry, Technology Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 30 2026 within Technology SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Ncr Atleos Corporation-0.09%$ -0.091 millions
Gartner Inc -0.62%$ -0.623 millions
Netgear Inc -0.83%$ -0.833 millions
Viasat Inc -1.24%$ -1.239 millions
Goodrx Holdings Inc -1.31%$ -1.309 millions
Rapid7 Inc -1.52%$ -1.518 millions
Upwork Inc -1.68%$ -1.682 millions
Corsair Gaming Inc -1.73%$ -1.731 millions
Unisys Corp-2.03%$ -2.028 millions
Pitney Bowes Inc-2.25%$ -2.254 millions
Kimball Electronics Inc -2.34%$ -2.339 millions
Webtoon Entertainment Inc -2.82%$ -2.816 millions
Kyndryl Holdings Inc-3.34%$ -3.340 millions
Octave Intelligence Plc-3.61%$ -3.611 millions
First Solar Inc -3.73%$ -3.735 millions
Alpha And Omega Semiconductor Limited-3.90%$ -3.903 millions
Aether Holdings Inc -4.00%$ -4.003 millions
Qualcomm Inc-4.03%$ -4.033 millions
Osi Systems inc -4.19%$ -4.192 millions
Optex Systems Holdings Inc -4.32%$ -4.317 millions
Expensify Inc -4.81%$ -4.809 millions
Dxc Technology Co-5.06%$ -5.065 millions
Quarta rad Inc -5.16%$ -5.162 millions
Marketwise Inc -5.18%$ -5.181 millions
Wm Technology Inc -5.35%$ -5.354 millions
Lg Display Co Ltd -6.08%$ -6.084 millions
Magnachip Semiconductor Corporation-6.13%$ -6.127 millions
Csp inc-6.80%$ -6.797 millions
Ptc Inc -6.81%$ -6.812 millions
Upland Software Inc -7.19%$ -7.190 millions


About Bioscience Health Innovations, Revenue Growth Rates (BHIC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Bioscience Health Innovations Inc (CIK 1784440).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001096906-26-001173
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Bioscience Health Innovations Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.